Through in-depth analysis of related genes and signaling pathways, we propose that the dual role of inflammatory factors such as CCL2 in NAFLD and UC may provide new targets for future diagnosis and treatment. Here, CCL2 is linked to metabolic dysfunction-associated steatotic liver disease.